Johnson & Johnson (NYSE:JNJ) shares dipped today despite first-quarter results that topped the consensus forecast. The New Brunswick, N.J.-based company posted profits of $5.8 billion, or $2.17 per share, on sales of $20.7 billion for the three months ended March 29, 2020, for a 54.6% bottom-line gain on sales growth of 3.3%. Adjusted to exclude one-time […]
Johnson and Johnson
These medical devices are getting ready to launch in 2020
Despite the COVID-19 pandemic, medical device companies are still working to gain regulatory approvals and launch new devices this year. The pandemic has largely fixed the FDA’s focus on emergency use authorizations (EUAs), leaving more typical device approvals waiting. At press time, the regulatory agency had granted 84 EUAs beginning Feb. 4 and had approved […]
How Johnson & Johnson is expanding manufacturing for a potential coronavirus vaccine
Johnson & Johnson (NYSE:JNJ) recently announced that its Janssen Pharmaceutical Cos. will collaborate with Emergent BioSolutions to support the manufacturing of its lead investigational COVID-19 vaccine candidate. The New Brunswick, N.J.–based pharmaceutical and medical device giant described the deal as the first in a series of contract manufacturing agreements that it expects to ink as it seeks […]
DeviceTalks Weekly Podcast: Ep.5 — How can startups move forward during a pandemic?
Raising capital for startup is never easy. Try doing it during a pandemic. In this week’s DeviceTalks Weekly, we’ll try to help entrepreneurs by talking with two guests who are committed to helping startups find the funding they need. Paul Grand, founder and CEO of MedTech Innovator, explains how he’s working to keep startups connected […]
How is coronavirus vaccine development going in the U.S.?
Researchers in Pittsburgh and Boston are moving forward with research into two separate vaccine programs against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. The work of the University of Pittsburgh School of Medicine researchers is detailed in a paper published recently in EBioMedicine, which is published by the Lancet. Delivery of the vaccine involved a microneedle array to […]
DePuy Synthes wins CE Mark for hip replacement dual mobility system
Johnson & Johnson’s (NYSE:JNJ) DePuy Synthes announced that it won CE Mark approval for its Bi-Mentum dual mobility system for people with a higher risk of dislocation. Bi-Mentum is designed with a standard femoral head articulating within a large polyethylene liner that swivels within a metal shell, reducing the risk of dislocation, which can impact patient satisfaction […]
J&J’s Janssen, Thermo Fisher Scientific to collaborate on oncology diagnostic
Thermo Fisher Scientific (NYSE:TMO) announced today that it entered into an agreement with Johnson & Johnson‘s (NYSE:JNJ) Janssen Biotech to co-develop a companion diagnostic (CDx) in oncology. Under the agreement, Thermo Fisher is set to collaborate with Janssen’s R&D scientists to validate biomarkers for use with Thermo Fisher’s Oncomine DX target test in identifying variant-positive patients for […]
J&J’s Ethicon mostly fends off Intuitive Surgical’s robotic surgery patent challenge
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon has kept most of a surgical robotics tool patent intact after a Patent Trial and Appeal Board decision on a challenge from rival Intuitive Surgical (NSDQ:ISRG). The board’s decision, dated Feb. 18, involved an Ethicon patent for a “Shiftable Drive Interface for Robotically-Controlled Surgical Tool,” issued in 2013. Out of […]
These medical device companies provide the most research payments
The worlds largest medical device companies are spending tens of millions of dollars a year on research payments to doctors and teaching hospitals — but the payments only make up a tiny fraction of their budgets. That was a big takeaway from an analysis of Medical Design & Outsourcing‘s annual Big 100 and the most […]
J&J to acquire remaining stake in Verb Surgical
Johnson & Johnson (NYSE:JNJ) announced today that it agreed to acquire the remaining stake in Verb Surgical, following a successful strategic collaboration with Alphabet (NSDQ:GOOGL) life sciences unit Verily. Verb Surgical’s robotics and data science capabilities were the driving force behind Johnson & Johnson’s decision to combine with the company as it seeks to advance medical interventions, making […]
B. Braun Medical names new chairman & CEO
B. Braun Medical has announced that Jean-Claude Dubacher will succeed longtime company leader Carroll Neubauer as chairman and CEO on Jan. 1, 2020. Neubauer will stay on as chairman and CEO of B. Braun of America, which owns B. Braun Medical (Bethlehem, Pa.), admixture pharmaceutical firm CAPS, Aesculap and B.Braun Interventional Systems. He has been […]